Jun 4, 2024 04:18PM
Jun 4, 2024 04:05PM
May 31, 2024 04:05PM
May 29, 2024 04:07PM
May 29, 2024 04:05PM
May 7, 2024 07:00AM
Apr 25, 2024 04:34PM Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Order
Mar 20, 2024 04:05PM
Mar 19, 2024 10:00AM
Mar 19, 2024 04:13AM
Mar 19, 2024 03:00AM
Dec 27, 2023 03:19AM
Oct 16, 2023 07:50AM
Oct 16, 2023 07:50AM Fusion Pharmaceuticals Appoints Life Science Industry Leaders Jeremy Bender, Teresa Bitetti and David Meek to its Board of Directors
Aug 8, 2023 07:00AM
May 11, 2023 07:16AM
May 11, 2023 07:15AM
Mar 16, 2023 07:30AM
Feb 13, 2023 04:06PM
Feb 13, 2023 04:05PM
Nov 8, 2022 07:00AM Fusion Pharmaceuticals Announces Third Quarter 2022 Financial Results and Clinical Program Updates
Nov 7, 2022 04:25PM
Nov 7, 2022 04:25PM
May 25, 2022 03:00PM
Mar 17, 2022 07:06AM
Mar 17, 2022 07:00AM
Nov 9, 2021 07:30AM
Nov 2, 2021 04:16PM Fusion Pharmaceuticals Inc. (FUSN) Appoints Christopher Leamon as Chief Scientific Officer
Nov 2, 2021 04:15PM
Sep 21, 2021 08:35AM
Aug 10, 2021 07:30AM
May 11, 2021 07:30AM
Apr 1, 2021 04:15PM
Mar 25, 2021 07:30AM
Mar 2, 2021 07:39AM Fusion Pharmaceuticals (FUSN) to Expand Pipeline with Acquisition of IPN-1087, a Small Molecule Targeting NTSR1, from Ipsen
Mar 2, 2021 07:30AM
Nov 2, 2020 09:31AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All